Xin Li

Dr. Xin Li

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2024 in Toxics
Verified
Journal Article
Open access
PDF file
JHJiang yu Hang
Jiang yu Hang
JSJingwen Si
Jingwen Si
YWYuhang Wang
Yuhang Wang
HZHan Zhang
Han Zhang
FZFang Zhou
Fang Zhou
WZWang Zheng
Wang Zheng
Air pollutants have both acute and chronic impacts on human health, affecting multiple systems and organs. While PM2.5 exposure is commonly assumed to be strongly associated with all respiratory diseases, this relationship has not been systematically analyzed. This study employed a two-sample Mendelian randomization approach to investigate the effects of PM2.5 on eight common lung diseases, using data from GWAS. Additionally, multivariable Mendelian randomization was applied to assess the direct effects of various air pollutants and the mediating roles of common factors such as BMI and smoking. At a significance threshold of 5×10−8, PM2.5 showed a significant causal relationship with both asthma and COPD. When the screening threshold was relaxed to 5× 10−6, this exposure continued to demonstrate significant associations not only with asthma and COPD, but also with other respiratory diseases, including pneumonia, emphysema/chronic bronchitis, and lung cancer. In the multivariable Mendelian randomization analysis, which controlled for smoking and bacterial infections, the association with pneumonia became non-significant, while the relationships with the other four diseases persisted. This study provides a systematic exploration of the relationship between PM2.5 and eight pulmonary diseases from a new perspective, deepening our understanding of the impact of air pollution on health and laying the foundation for future efforts to mitigate these effects.

25 July 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
QMQiuqiao Mu
Qiuqiao Mu
HZHan Zhang
Han Zhang
YSYing Shi
Ying Shi
MXMengli Xue
Mengli Xue
JWJingxian Wang
Jingxian Wang
DSDaqiang Sun
Daqiang Sun
Background: Lymph node metastasis markedly worsens prognosis in lung adenocarcinoma (LUAD); however, the evolutionary dynamics and regulatory mechanisms underlying the heterogeneity of malignant epithelial cells during this process remain poorly understood and warrant comprehensive investigation.Methods: We performed a comprehensive single-cell transcriptomic analysis of epithelial cells from 18 samples comprising normal lung tissue and lymph node metastases. Malignant epithelial cells were identified via inferred copy number variation (CNV) profiles. Key malignant subpopulations were further characterized through trajectory inference, cell–cell communication mapping, gene set variation analysis (GSVA), and reconstruction of transcription factor regulatory networks. To assess clinical relevance, we developed and validated a prognostic model—termed the EAS score—based on the transcriptional signatures of malignant epithelial subsets, using integrated data from multiple TCGA and GEO cohorts. The functional role of the hub gene SELENBP1 was experimentally validated through quantitative PCR (qPCR), Western blotting, immunohistochemistry (IHC), Transwell migration assays, colony formation assays, flow cytometry, ROS quantification, and subcutaneous tumorigenesis assays in vivo.Results: Single-cell transcriptomic analysis identified four distinct malignant epithelial subtypes (Clusters 0–3), each characterized by unique patterns of CNV. Leveraging these defined cellular subpopulations, we constructed a highly accurate model for prognostication in LUAD, enabling reliable classification of patients based on clinical outcomes. Through detailed comparisons between groups with divergent prognostic risks, the study revealed notable differences across the tumor microenvironment (TME), including alterations in pathway activity, gene enrichment distributions, mutation profiles, and anticipated responses to immune checkpoint blockade. In addition, functional validation experiments confirmed that SELENBP1 plays a tumor-suppressive role, further supporting its relevance as a potential intervention target in LUAD.Conclusion: This research provides insights into the evolutionary complexity and heterogeneity of malignant epithelial populations in lymph node metastatic sites of LUAD. It also presents a scoring system based on prognostic indicators, which serves as a reliable tool for forecasting patient survival outcomes. Moreover, the discovery of SELENBP1 as a candidate tumor suppressor emphasizes its importance in guiding both clinical risk categorization and the design of personalized treatment strategies for individuals classified as high-risk LUAD cases.

2 January 2026 in Cancers
Verified
Journal Article
Open access
PDF file
SZShuai Zhao
Shuai Zhao
HZHan Zhang
Han Zhang
QMQingqing Ma
Qingqing Ma
JHJiang yu Hang
Jiang yu Hang
XZXiaojiang Zhao
Xiaojiang Zhao
DSDaqiang Sun
Daqiang Sun
Background: Lung adenocarcinoma (LUAD) exhibits pronounced cellular and molecular heterogeneity that shapes tumor progression and therapeutic response. Although nucleotide metabolism is essential for sustaining tumor proliferation and coordinating immune interactions, its single-cell heterogeneity and clinical implications remain incompletely defined. Methods: We integrated a publicly available scRNA-seq dataset derived from independent LUAD patients to construct a comprehensive LUAD cellular atlas, identified malignant epithelial cells using inferCNV, and reconstructed differentiation trajectories via Monocle2. Cell–cell communication patterns under distinct nucleotide metabolic states were assessed using CellChat. A nucleotide metabolism-related signature (NMRS) was subsequently developed across TCGA-LUAD and multiple GEO cohorts using 101 combinations of machine learning algorithms. Its prognostic and immunological predictive value was systematically evaluated. The functional relevance of the key gene ENO1 was further verified through pan-cancer analyses and in vitro experiments. Results: We identified substantial nucleotide metabolic heterogeneity within malignant epithelial cells, closely linked to elevated proliferative activity, glycolytic activation, and increased CNV burden. Pseudotime analysis showed that epithelial cells gradually acquire enhanced immune-modulatory and complement-related functions along their differentiation continuum. High-metabolism epithelial cells exhibited stronger outgoing communication—particularly via MIF, CDH5, and MHC-II pathways—highlighting their potential role in shaping an immunosuppressive microenvironment. The NMRS built from metabolism-related genes provided robust prognostic stratification across multiple cohorts and surpassed conventional clinical parameters. Immune profiling revealed that high-NMRS tumors displayed increased T-cell dysfunction, stronger exclusion, higher TIDE scores, and lower IPS, suggesting poorer responses to immune checkpoint blockade. ENO1, markedly upregulated in high-NMRS tumors and functioning as a risk factor in several cancer types, was experimentally shown to promote invasion in LUAD cell lines. Conclusions: This study delineates the profound impact of nucleotide metabolic reprogramming on epithelial cell states, immune ecology, and malignant evolution in LUAD. The NMRS provides a robust predictor of prognosis and immunotherapy response across cohorts, while ENO1 emerges as a pivotal metabolic–immune mediator and promising therapeutic target.

1 April 2018 in Medicine
Verified
Journal Article
Open access
XLXin Li
Xin Li
MWMeng Wang
Meng Wang
DSDaqiang Sun
Daqiang Sun
Sclerosing thymoma is an extremely rare mediastinal neoplasm; it was recognized for the first time in 1994 and to date only 15 cases have been reported. The present study report a case of a 65-year-old man who was incidentally found to have an anterior mediastinal nodule, without clinical symptoms including fever, chest pain, and myasthenia gravis. The chest computed tomography (CT) revealed the nodule was 4.9 × 4.2 × 3.0 cm in size. And the microscopic and immunohistochemical findings indicated that the final diagnosis was sclerosing thymoma. The anterior mediastinal nodule was completely removed. No evidence of recurrence or complication was found in the second year after surgery. The biologic behavior of the rare sclerosing thymoma is still largely mysterious; it is utmost importance to classify the sclerosing thymoma from other mediastinal tumors. Its prognosis is favorable and thymectomy is currently the mainstay of treatment.

10 September 2025 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
QMQiuqiao Mu
Qiuqiao Mu
YJYuhao Jing
Yuhao Jing
YDYun Ding
Yun Ding
JWJingxian Wang
Jingxian Wang
HZHan Zhang
Han Zhang
DSDaqiang Sun
Daqiang Sun
Background: Small cell lung cancer (SCLC) is a highly aggressive and rapidly progressing form of lung cancer that is difficult to treat. Immunotherapy has provided encouraging outcomes, but only a small proportion of patients experience significant benefit. Predicting which patients will respond to immunotherapy is essential for maximizing treatment effectiveness.Methods: This retrospective analysis included 319 SCLC patients from multiple centers in China who underwent immune checkpoint inhibitor (ICI) therapy. Clinical features and peripheral blood biomarkers were used together to create a prediction system. This system aims to forecast overall survival (OS) and progression-free survival (PFS). Univariate and multivariate Cox regression analyses were used to identify prognostic factors. A nomogram was then constructed to perform risk stratification. The model’s performance was evaluated using multiple methods. Time-dependent ROC analysis was applied to assess its predictive accuracy. Decision curve analysis (DCA) was used to determine its clinical utility. Additionally, calibration plots were created to examine the model’s consistency with actual outcomes.Results: In SCLC patients, age, brain metastasis, cigarettes per day, lnNSE (Natural Logarithm of Neuron-Specific Enolase), lnAISI (Natural Logarithm of the Aggregate Immune-Inflammatory Index), and lnCLR (Natural Logarithm of the CRP-to-Albumin Ratio) were found to be key factors affecting OS. A nomogram incorporating six variables exhibited excellent discrimination, calibration, and practical utility in both training and validation cohorts. Notably, lnAISI and lnCLR, indicators of systemic immune-inflammation, showed significant predictive value.Conclusion: This study developed a convenient and effective multi-factor survival prediction model based on clinical and hematological markers. The model provides a tool for personalized management of immunotherapy in SCLC patients. It offers new insights and practical evidence for precision treatment in SCLC.

20 July 2024 in Journal of Innovative Optical Health Sciences
Verified
Journal Article
Open access
YDYun Ding
Yun Ding
ZYZhuoqun Yuan
Zhuoqun Yuan
XZXiaojiang Zhao
Xiaojiang Zhao
GGGuozheng Gao
Guozheng Gao
XLXin Li
Xin Li
YLYanmei Liang
Yanmei Liang
The low detection rate of Mycobacterium tuberculosis in clinical practice leads to a high rate of missed diagnosis for pulmonary tuberculosis (PTB). As a noninvasive, high-resolution, real-time imaging technology, polarization-sensitive optical coherence tomography (PS-OCT) may be feasible for the rapid identification of pathological feature. This study aimed to explore the feasibility of using PS-OCT to identify pathological features of PTB. In the experiments, PTB samples containing some surrounding lung tissues were imaged using PS-OCT. It is demonstrated that PS-OCT images showed good consistency with the corresponding pathological images and were able to identify PTB-related characteristic pathological regions. We think PS-OCT can serve as an effective supplement for the diagnosis of PTB, enabling rapid and accurate diagnosis, and aiding in the understanding of the pathological characteristics and pathophysiological processes of PTB.